Albert Bourla, Pfizer Chairman & CEO, addresses the current state of US vaccinations and the robust growth in Pfizer's ...

Pfizer CEO Albert Bourla details $70B US investment in manufacturing and R&D, discussing oncology advancements, the GLP-1 drug race, and AI's transformative role in drug development on 'Mornings with ...

Through July 4, The Post, in conjunction with the Milken Center for Advancing the American Dream, is featuring US citizens explaining what the American dream means to them in 2026 — including Albert ...

Pfizer (PFE) CEO and chairman Albert Bourla told Yahoo Finance Executive Editor Brian Sozzi during Yahoo Finance's annual Investconference that the $10 billion acquisition of GLP-1 maker Metsera (MTSR ...

Add Yahoo as a preferred source to see more of our stories on Google. Dr. Albert Bourla, chairman and CEO of drugmaker Pfizer, says mRNA technology is "extremely well-tested." - Dia Dipasupil/Getty ...

Pfizer's business may be in better shape than investors think.

Pfizer (PFE) CEO Albert Bourla said he's learned to work with some unlikely allies — even those who once questioned the very foundation of his business. "Clearly, that was not going to be my choice ...

Pfizer Inc. (NYSE:PFE) is among the Best Healthcare Stocks. On June 23, Reuters reported that Pfizer Inc. (NYSE:PFE) ‘s Chief ...

By Maggie Fick, Bhanvi Satija and Patricia Weiss LONDON/FRANKFURT, June 10 (Reuters) - Pfizer is reviewing the timing and scope of planned investments in Germany, CEO Albert Bourla said in a letter to ...

Pfizer's CEO thinks his company will make big waves in the weight loss market. Eli Lilly does have a strong hold on the industry and won't let go anytime soon. Even so, Lilly could carve out a niche ...